Abstract Head and neck paragangliomas (HNPs) and pheochromocytomas are rare tumors. Catecholamine secreting tumors that arise from chromaffin cells of the adrenal medulla and the sympathetic ganglia are referred to as pheochromocytomas and extra adrenal catecholamine secreting paragangliomas (extra adrenal pheochromocytomas) respectively. The distinction between pheochromocytoma and paraganglioma is an important one because of implications for associated neoplasms, risk for malignancy, and genetic testing. Paragangliomas are rare tumors of the head and neck and are of diagnostic challenge. We report a case of 55 year old male who had a neck swelling, cough with expectoration, which on extensive evaluation revealed to be Paraganglioma with primary optic atrophy.
A male patient aged 55 years was admitted to the medical ward for the treatment of bronchitis 2 months ago when a swelling was noticed on the right side of his neck which was asymptomatic in nature.
On Examination A 3 9 4 cm swelling was seen on the right side of the neck at the level of lower 1/3rd of SCM. It was immobile, firm in consistency. Swelling was compressible, increased in size on valsalva maneouver (Figs. 1, 2) and decreased in size on contraction of the SCM. Transmitted pulsations felt. There was no local rise of temperature or tenderness.
Investigations
The following investigations were done:
Routine investigations Liver function tests Thyroid profile VMA The above were within normal limits Ophthalmology examination revealed bilateral primary optic atrophy.
CT Scan
Brain: Normal Neck and Thorax: (Fig. 3) A significantly enhancing soft tissue mass seen adjacent to the right lobe of the thyroid at the level of the bifurcation of the brachiocephalic trunk deep to the SCM. Right Para tracheal and supraclavicular lymphadenopathy noted. Features were suggestive of paraganglioma.
USG Neck
A well defined lobulated highly vascular mass seen in the right lower neck with:
• Tortuous vessels along the periphery • A spindle shaped mass seen arising from a nerve trunk lateral to the CCA and just superior to the Brachiocephalic trunk (Fig. 4) . • Excision (Figs. 5, 6, 7).
• Pleura of the right lung was intact.
• Vagus nerve palpated deep to Common Carotid artery.
• Specimen (Fig. 8 ) sent for HPE.
Post Operative Period
Post operative period was uneventful There were no signs of carotid sinus syndrome. 2 pints of cross matched blood was transfused. Patient was mobilized on the first post operative day.
HPE
HPE showed epitheloid cells arranged in Zellballen pattern with a ( Fig. 9 ) fibrous surrounding layer of sustentacular cells with interspersed blood vessels.
Discussion
Approximately 10 % of Head and neck paragangliomas and pheochromocytomas have been cited to be malignant. Benign as well as malignant HNPs consist of the same two major cell types: epithelioid chief cells and sustentacular supporting cells. These two cell types form clusters of Indian J Otolaryngol Head Neck Surg (July 2013) 65(Suppl 1):S167-S170 S169 cells, so-called Zellballen, that are surrounded by extensive vascular sinusoids. Interestingly, no accepted pathological or immunohistochemical markers distinguish malignant from benign paraganglial tumors [1] . The distinction between pheochromocytoma and paraganglioma is an important one because of implications for associated neoplasms, risk for malignancy and genetic testing. Pargangliomas are found where there is chromaffin tissue, along the Para aortic sympathetic chain, within the organs of zukerkandl (at the origin of the inferior mesenteric artery), in the wall of urinary bladder and along the sympathetic chain in the neck or mediastinum. Odd locations for paragangliomas include the intra-atrial cardiac septum, spermatic cord, vagina, scrotum and sacrococcygeal region. Paragangliomas in the head and neck region (carotid body tumors, glomus tumors, chemodectomas) usually arise from parasympathetic tissue and typically do not hyper secrete catecholamine and metanephrines. Where as paragangliomas in the mediastinum, abdomen and pelvis usually arise from sympathetic chromaffin tissue and usually do hyper secrete catecholamine and metanephrines. Familial paragangliomas is an autosomal dominant disorder characterized by paragangliomas that are located most often in the head and neck but also in the thorax, abdomen, pelvis and urinary bladder. Approximately 5 % of head and neck paragangliomas and more than 50 % of abdominal paragangliomas produce hormones. Most cases of familial paragangliomas are caused by mutations in the succinate dehydrogenase (SDH; SDHB, SDHC, SDHD). The prevalence of familial paragangliomas is unknown. Druck et al. [2] had found 19 % incidence of malignancy. Regional lymph nodes and lungs are common sites of secondaries. Paraganglioma syndromes may be increased in those who live in high altitudes or are chronically exposed to hypoxic conditions. Avoidance of habitation at high altitudes and activities that promote long-term exposure to hypoxia should be considered. Activities such as cigarette smoking that predispose to chronic lung disease should be discouraged in persons who have a mutation in SDHD, SDHC or SDHB. By age ten years or at least ten years before the earliest age at diagnosis in the family, presymptomatic testing, including genetic testing, should be offered to all first-degree relatives of an individual in whom a mutation in SDHD, SDHC or SDHB has been detected. Use of molecular genetic testing for early identification of at-risk family members improves diagnostic certainty and reduces the need for costly screening procedures in those at-risk family members who have not inherited a disease-causing mutation [3] .
Conclusion
Approximately 30 % of apparently sporadic HNPs are caused by a germ line mutation in one of the SDHB, SDHC and SDHD genes. We therefore recommend molecular genetic screening of all HNP patients for those mutations. Firstdegree relatives of mutation carriers have to be screened as well. There is an autosomal-dominant role of transmission for all PGLs with a parent-of-origin-dependent inheritance in SDHD mutation carriers (PGL 1). Patients with PGL 1 and 4 have a very high lifetime risk for the development of HNP as well as thoracic and abdominal paraganglionic tumors. Compared with sporadic HNP, tumors in SDHB, SDHC and SDHD mutation carriers develop at a significantly younger age. The SDHB mutations are associated with a high percentage of malignant PGLs. Three-body regions clinical screening of mutation carriers offers the chance to diagnose those tumors in an early and asymptomatic stage. Appropriately timed surgical intervention will minimize disease-specific morbidity and mortality.
We present a case of Head and neck paraganglioma with primary optic atrophy where early detection through surveillance and removal of tumors may prevent or minimize complications related to mass effect hyper secretion, and malignant transformation.
